Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 395

1.

Oligodendroglial connexin 47 regulates neuroinflammation upon autoimmune demyelination in a novel mouse model of multiple sclerosis.

Zhao Y, Yamasaki R, Yamaguchi H, Nagata S, Une H, Cui Y, Masaki K, Nakamuta Y, Iinuma K, Watanabe M, Matsushita T, Isobe N, Kira JI.

Proc Natl Acad Sci U S A. 2020 Jan 13. pii: 201901294. doi: 10.1073/pnas.1901294117. [Epub ahead of print]

PMID:
31932428
2.

Insulin deficiency promotes formation of toxic amyloid-β42 conformer co-aggregating with hyper-phosphorylated tau oligomer in an Alzheimer's disease model.

Imamura T, Yanagihara YT, Ohyagi Y, Nakamura N, Iinuma KM, Yamasaki R, Asai H, Maeda M, Murakami K, Irie K, Kira JI.

Neurobiol Dis. 2020 Jan 9:104739. doi: 10.1016/j.nbd.2020.104739. [Epub ahead of print]

3.

Persister Cells Resuscitate Using Membrane Sensors that Activate Chemotaxis, Lower cAMP Levels, and Revive Ribosomes.

Yamasaki R, Song S, Benedik MJ, Wood TK.

iScience. 2020 Jan 24;23(1):100792. doi: 10.1016/j.isci.2019.100792. Epub 2019 Dec 21.

4.

Novel Neuropathic Pain Mechanisms Associated With Allergic Inflammation.

Fujii T, Yamasaki R, Kira JI.

Front Neurol. 2019 Dec 17;10:1337. doi: 10.3389/fneur.2019.01337. eCollection 2019. Review.

5.

Corrigendum to "Higher postictal parasympathetic activity following greater ictal heart rate increase in right- than left-sided seizures" [Epilepsy Behav 97 (2019) 161-168].

Shimmura M, Uehara T, Ogata K, Shigeto H, Maeda T, Sakata A, Yamasaki R, Kira JI.

Epilepsy Behav. 2020 Jan 2:106865. doi: 10.1016/j.yebeh.2019.106865. [Epub ahead of print] No abstract available.

PMID:
31902647
6.

The effects of chronic subthalamic stimulation on nonmotor symptoms in advanced Parkinson's disease, revealed by an online questionnaire program.

Kawaguchi M, Samura K, Miyagi Y, Okamoto T, Yamasaki R, Sakae N, Yoshida F, Iihara K.

Acta Neurochir (Wien). 2020 Feb;162(2):247-255. doi: 10.1007/s00701-019-04182-y. Epub 2020 Jan 2.

PMID:
31897728
7.

Characteristic analysis of the fermentation and sporulation properties of the traditional sake yeast strain Hiroshima no.6.

Yamasaki R, Goshima T, Oba K, Isogai A, Ohdoi R, Hirata D, Akao T.

Biosci Biotechnol Biochem. 2019 Dec 22:1-12. doi: 10.1080/09168451.2019.1706441. [Epub ahead of print]

PMID:
31868109
8.

Unique HLA haplotype associations in IgG4 anti-neurofascin 155 antibody-positive chronic inflammatory demyelinating polyneuropathy.

Ogata H, Isobe N, Zhang X, Yamasaki R, Fujii T, Machida A, Morimoto N, Kaida K, Masuda T, Ando Y, Kuwahara M, Kusunoki S, Nakamura Y, Matsushita T, Kira JI.

J Neuroimmunol. 2020 Feb 15;339:577139. doi: 10.1016/j.jneuroim.2019.577139. Epub 2019 Dec 16.

PMID:
31864140
9.

Evaluation of thrombotic events in patients with immune thrombocytopenia.

Ito S, Fujiwara SI, Ikeda T, Toda Y, Mashima K, Umino K, Minakata D, Nakano H, Yamasaki R, Kawasaki Y, Sugimoto M, Ashizawa M, Yamamoto C, Hatano K, Sato K, Oh I, Ohmine K, Muroi K, Kanda Y.

Ann Hematol. 2020 Jan;99(1):49-55. doi: 10.1007/s00277-019-03886-6. Epub 2019 Dec 18.

PMID:
31853702
10.

Differences between predictive factors for early neurological deterioration due to hemorrhagic and ischemic insults following intravenous recombinant tissue plasminogen activator.

Tanaka K, Matsumoto S, Furuta K, Yamada T, Nagano S, Takase KI, Hatano T, Yamasaki R, Kira JI.

J Thromb Thrombolysis. 2019 Dec 17. doi: 10.1007/s11239-019-02015-4. [Epub ahead of print]

PMID:
31848874
11.

Central nervous system-specific antinuclear antibodies in patients with multiple sclerosis.

Fujii T, Yamasaki R, Miyachi Y, Nagata S, Maimaitijiang G, Nakamura Y, Shinoda K, Matsushita T, Isobe N, Kira JI.

J Neurol Sci. 2019 Dec 6;409:116619. doi: 10.1016/j.jns.2019.116619. [Epub ahead of print]

PMID:
31835211
12.

Environmental risk factors for multiple sclerosis in Japanese people.

Sakoda A, Matsushita T, Nakamura Y, Watanabe M, Shinoda K, Masaki K, Isobe N, Yamasaki R, Kira JI.

Mult Scler Relat Disord. 2019 Nov 25;38:101872. doi: 10.1016/j.msard.2019.101872. [Epub ahead of print]

PMID:
31812038
13.

Salvage Chemotherapy Followed by Autologous Stem-Cell Transplantation Using Targeted Busulfan for Refractory Diffuse Large B-Cell Lymphoma With Dialysis-Dependent End-Stage Renal Disease.

Morita K, Ashizawa M, Toda Y, Ikeda T, Kawaguchi SI, Ito S, Ochi SI, Nagayama T, Mashima K, Umino K, Minakata D, Nakano H, Yamasaki R, Yamamoto C, Hatano K, Fujiwara SI, Sato K, Oh I, Ohmine K, Muroi K, Matsumoto K, Kanda Y.

Clin Lymphoma Myeloma Leuk. 2019 Nov 7. pii: S2152-2650(19)32101-9. doi: 10.1016/j.clml.2019.11.004. [Epub ahead of print]

PMID:
31787588
14.

A case of overlapping adult-onset linear scleroderma and Parry-Romberg syndrome presenting with widespread ipsilateral neurogenic involvement.

Yamasaki R, Yonekawa T, Inamizu S, Shinoda K, Ochi H, Matsushita T, Isobe N, Tsuji G, Sadashima S, Kuma Y, Oda Y, Iwaki T, Furue M, Kira JI.

Neuropathology. 2019 Nov 27. doi: 10.1111/neup.12614. [Epub ahead of print]

PMID:
31775183
15.

Multiple Sclerosis.

Yamasaki R, Kira JI.

Adv Exp Med Biol. 2019;1190:217-247. doi: 10.1007/978-981-32-9636-7_14. Review.

PMID:
31760647
16.

Modified diffusion-weighted imaging-Alberta Stroke Program Early Computed Tomography Score including deep white matter lesions predicts symptomatic intracerebral hemorrhage following intravenous thrombolysis.

Tanaka K, Matsumoto S, Furuta K, Yamada T, Nagano S, Takase KI, Hatano T, Yamasaki R, Kira JI.

J Thromb Thrombolysis. 2019 Nov 19. doi: 10.1007/s11239-019-01979-7. [Epub ahead of print]

PMID:
31745858
17.

A Visual Task Management Application for Acute Ischemic Stroke Care.

Matsumoto S, Koyama H, Nakahara I, Ishii A, Hatano T, Ohta T, Tanaka K, Ando M, Chihara H, Takita W, Tokunaga K, Hashikawa T, Funakoshi Y, Kamata T, Higashi E, Watanabe S, Kondo D, Tsujimoto A, Furuta K, Ishihara T, Hashimoto T, Koge J, Sonoda K, Torii T, Nakagaki H, Yamasaki R, Nagata I, Kira JI.

Front Neurol. 2019 Oct 30;10:1118. doi: 10.3389/fneur.2019.01118. eCollection 2019.

18.

The impact of overweight on renal toxicity in patients treated with dexamethasone, high-dose cytarabine, and cisplatin.

Umino K, Hatano K, Ochi SI, Genda H, Ikeda T, Kawaguchi SI, Toda Y, Ito S, Nagayama T, Mashima K, Minakata D, Nakano H, Yamasaki R, Morita K, Yamamoto C, Ashizawa M, Sato K, Oh I, Fujiwara SI, Ohmine K, Muroi K, Kanda Y.

Int J Hematol. 2019 Nov 14. doi: 10.1007/s12185-019-02779-8. [Epub ahead of print]

PMID:
31728828
19.

Branchial myorhythmia in a case of systemic lupus erythematosus.

Une H, Matsuse D, Uehara T, Kikuchi Y, Inamizu S, Yamasaki R, Tobimatsu S, Shibasaki H, Kira JI.

J Neurol Sci. 2020 Jan 15;408:116501. doi: 10.1016/j.jns.2019.116501. Epub 2019 Oct 15. No abstract available.

PMID:
31715328
20.

Analysis of the cost-effectiveness of treatment strategies for CML with incorporation of treatment discontinuation.

Yamamoto C, Nakashima H, Ikeda T, Kawaguchi SI, Toda Y, Ito S, Mashima K, Nagayama T, Umino K, Minakata D, Nakano H, Morita K, Yamasaki R, Sugimoto M, Ishihara Y, Ashizawa M, Hatano K, Sato K, Oh I, Fujiwara SI, Ueda M, Ohmine K, Muroi K, Kanda Y.

Blood Adv. 2019 Nov 12;3(21):3266-3277. doi: 10.1182/bloodadvances.2019000745.

21.

Drama students with and without vocal complaint: vocal health and hygiene data, symptoms and voice handicap.

Cruz MRDSA, Yamasaki R, Pacheco C, Borrego MCM, Behlau M.

Codas. 2019 Oct 31;31(5):e20180319. doi: 10.1590/2317-1782/20192018319. eCollection 2019. Portuguese, English.

22.

Intrathecal cytokine profile in neuropathy with anti-neurofascin 155 antibody.

Ogata H, Zhang X, Yamasaki R, Fujii T, Machida A, Morimoto N, Kaida K, Masuda T, Ando Y, Kuwahara M, Kusunoki S, Nakamura Y, Matsushita T, Isobe N, Kira JI.

Ann Clin Transl Neurol. 2019 Nov;6(11):2304-2316. doi: 10.1002/acn3.50931. Epub 2019 Oct 27.

23.

Interkingdom signal indole inhibits Pseudomonas aeruginosa persister cell waking.

Zhang W, Yamasaki R, Song S, Wood TK.

J Appl Microbiol. 2019 Dec;127(6):1768-1775. doi: 10.1111/jam.14434. Epub 2019 Oct 8.

PMID:
31487414
24.

Serum GFAP and neurofilament light as biomarkers of disease activity and disability in NMOSD.

Watanabe M, Nakamura Y, Michalak Z, Isobe N, Barro C, Leppert D, Matsushita T, Hayashi F, Yamasaki R, Kuhle J, Kira JI.

Neurology. 2019 Sep 24;93(13):e1299-e1311. doi: 10.1212/WNL.0000000000008160. Epub 2019 Aug 30.

PMID:
31471502
25.

Alloreactive T Cells Display a Distinct Chemokine Profile in Response to Conditioning in Xenogeneic GVHD Models.

Kawasaki Y, Sato K, Nakano H, Hayakawa H, Izawa J, Takayama N, Mashima K, Oh I, Minakata D, Yamasaki R, Morita K, Ashizawa M, Yamamoto C, Hatano K, Fujiwara SI, Ohmine K, Muroi K, Ito R, Hayakawa M, Ohmori T, Kanda Y.

Transplantation. 2019 Sep;103(9):1834-1843. doi: 10.1097/TP.0000000000002756.

PMID:
31461746
26.

Comparison of Danaparoid Sodium and Synthetic Protease Inhibitors for the Treatment of Disseminated Intravascular Coagulation Associated with Hematological Malignancies: A Retrospective Analysis.

Minakata D, Fujiwara SI, Hayakawa J, Nakasone H, Ikeda T, Kawaguchi SI, Toda Y, Ito S, Ochi SI, Nagayama T, Mashima K, Umino K, Nakano H, Yamasaki R, Morita K, Kawasaki Y, Sugimoto M, Ishihara Y, Yamamoto C, Ashizawa M, Hatano K, Sato K, Oh I, Ohmine K, Muroi K, Ohmori T, Kanda Y.

Acta Haematol. 2019 Aug 28:1-10. doi: 10.1159/000501818. [Epub ahead of print]

PMID:
31461700
27.

Temporal Trends in Clinical Characteristics and Door-to-Needle Time in Patients Receiving Intravenous Tissue Plasminogen Activator: A Retrospective Study of 4 Hospitals in Japan.

Tanaka K, Matsumoto S, Yamada T, Nagano S, Takase KI, Hatano T, Yamasaki R, Kira JI.

J Stroke Cerebrovasc Dis. 2019 Nov;28(11):104305. doi: 10.1016/j.jstrokecerebrovasdis.2019.104305. Epub 2019 Aug 10.

PMID:
31405791
28.

Spinal cord involvement by atrophy and associations with disability are different between multiple sclerosis and neuromyelitis optica spectrum disorder.

Nakamura Y, Liu Z, Fukumoto S, Shinoda K, Sakoda A, Matsushita T, Hayashida S, Isobe N, Watanabe M, Hiwatashi A, Yamasaki R, Kira JI.

Eur J Neurol. 2020 Jan;27(1):92-99. doi: 10.1111/ene.14038. Epub 2019 Aug 2.

PMID:
31304648
29.

Intractable axonal neuropathy with multifocal peripheral nerve swelling in neuromyelitis optica spectrum disorders: A case report.

Mizuno Y, Shinoda K, Watanabe M, Ogata H, Isobe N, Matsushita T, Yamasaki R, Tanaka K, Koike H, Katsuno M, Kira JI.

Mult Scler Relat Disord. 2019 Oct;35:16-18. doi: 10.1016/j.msard.2019.06.033. Epub 2019 Jun 29.

PMID:
31279231
30.

Higher postictal parasympathetic activity following greater ictal heart rate increase in right- than left-sided seizures.

Shimmura M, Uehara T, Ogata K, Shigeto H, Maeda T, Sakata A, Yamasaki R, Kira JI.

Epilepsy Behav. 2019 Aug;97:161-168. doi: 10.1016/j.yebeh.2019.05.026. Epub 2019 Jun 25. Erratum in: Epilepsy Behav. 2020 Jan 2;:106865.

PMID:
31252273
31.

Predictive value of soluble interlukin-2 receptor level at diagnosis on the outcome for patients with classical Hodgkin lymphoma treated with ABVD with or without radiotherapy.

Umino K, Fujiwara SI, Ikeda T, Kawaguchi SI, Toda Y, Ito S, Ochi SI, Nagayama T, Mashima K, Minakata D, Nakano H, Yamasaki R, Morita K, Kawasaki Y, Yamamoto C, Ashizawa M, Hatano K, Sato K, Oh I, Ohmine K, Muroi K, Kanda Y.

Ann Hematol. 2019 Sep;98(9):2121-2129. doi: 10.1007/s00277-019-03738-3. Epub 2019 Jun 25.

PMID:
31240469
32.

Identification of a potent indigoid persister antimicrobial by screening dormant cells.

Song S, Gong T, Yamasaki R, Kim JS, Wood TK.

Biotechnol Bioeng. 2019 Sep;116(9):2263-2274. doi: 10.1002/bit.27078. Epub 2019 Jun 25.

PMID:
31161664
33.

Multiple mtDNA deletions due to mitochondrion toxicity of anti-hepadnaviral drugs: Comments to the letter from J. Finsterer.

Fujii T, Honda H, Yamasaki R, Iwaki T, Kira JI.

Neuropathology. 2019 Aug;39(4):326-327. doi: 10.1111/neup.12563. Epub 2019 May 21. No abstract available.

PMID:
31111547
34.

Cathepsin E in neutrophils contributes to the generation of neuropathic pain in experimental autoimmune encephalomyelitis.

Harada Y, Zhang J, Imari K, Yamasaki R, Ni J, Wu Z, Yamamoto K, Kira JI, Nakanishi H, Hayashi Y.

Pain. 2019 Sep;160(9):2050-2062. doi: 10.1097/j.pain.0000000000001596.

35.

σ54 -Dependent regulator DVU2956 switches Desulfovibrio vulgaris from biofilm formation to planktonic growth and regulates hydrogen sulfide production.

Zhu L, Gong T, Wood TL, Yamasaki R, Wood TK.

Environ Microbiol. 2019 Oct;21(10):3564-3576. doi: 10.1111/1462-2920.14679. Epub 2019 May 23.

PMID:
31087603
36.

Novel pathogenic XK mutations in McLeod syndrome and interaction between XK protein and chorein.

Urata Y, Nakamura M, Sasaki N, Shiokawa N, Nishida Y, Arai K, Hiwatashi H, Yokoyama I, Narumi S, Terayama Y, Murakami T, Ugawa Y, Sakamoto H, Kaneko S, Nakazawa Y, Yamasaki R, Sadashima S, Sakai T, Arai H, Sano A.

Neurol Genet. 2019 Apr 22;5(3):e328. doi: 10.1212/NXG.0000000000000328. eCollection 2019 Jun.

37.

N-Ethynylation of Anilides Decreases the Double-Bond Character of Amide Bond while Retaining trans-Conformation and Planarity.

Yamasaki R, Morita K, Iizumi H, Ito A, Fukuda K, Okamoto I.

Chemistry. 2019 Aug 1;25(43):10118-10122. doi: 10.1002/chem.201901451. Epub 2019 Jun 26.

PMID:
31050845
38.

Properties of Mean Shift.

Yamasaki R, Tanaka T.

IEEE Trans Pattern Anal Mach Intell. 2019 Apr 26. doi: 10.1109/TPAMI.2019.2913640. [Epub ahead of print]

PMID:
31034409
39.

Impact of the soluble interleukin-2 receptor level in the relapsed or refractory phase on the clinical outcome of patients with diffuse large B-cell lymphoma.

Umino K, Fujiwara SI, Ikeda T, Kawaguchi SI, Toda Y, Ito S, Ochi SI, Nagayama T, Mashima K, Minakata D, Nakano H, Yamasaki R, Morita K, Kawasaki Y, Yamamoto C, Ashizawa M, Hatano K, Sato K, Oh I, Ohmine K, Muroi K, Kanda Y.

Leuk Lymphoma. 2019 Aug;60(8):1926-1933. doi: 10.1080/10428194.2018.1564824. Epub 2019 Apr 5.

PMID:
30947577
40.

A novel model for treatment of hypertrophic pachymeningitis.

Cui Y, Masaki K, Zhang X, Yamasaki R, Fujii T, Ogata H, Hayashida S, Yamaguchi H, Hyodo F, Eto H, Koyama S, Iinuma K, Yonekawa T, Matsushita T, Yoshida M, Yamada K, Kawano M, Malissen M, Malissen B, Kira J.

Ann Clin Transl Neurol. 2019 Jan 15;6(3):431-444. doi: 10.1002/acn3.715. eCollection 2019 Mar.

41.

Discriminative clinical and neuroimaging features of motor-predominant hereditary diffuse leukoencephalopathy with axonal spheroids and primary progressive multiple sclerosis: A preliminary cross-sectional study.

Saitoh BY, Yamasaki R, Hiwatashi A, Matsushita T, Hayashi S, Mitsunaga Y, Maeda Y, Isobe N, Yoshida K, Ikeda SI, Kira JI.

Mult Scler Relat Disord. 2019 Jun;31:22-31. doi: 10.1016/j.msard.2019.03.008. Epub 2019 Mar 12.

PMID:
30901701
42.

Toxic myopathy with multiple deletions in mitochondrial DNA associated with long-term use of oral anti-viral drugs for hepatitis B: A case study.

Fujii T, Takase KI, Honda H, Kawamura N, Yamasaki R, Urata M, Uchiumi T, Iwaki T, Kira JI.

Neuropathology. 2019 Apr;39(2):162-167. doi: 10.1111/neup.12548. Epub 2019 Mar 7.

PMID:
30847961
43.

Ribosome dependence of persister cell formation and resuscitation.

Wood TK, Song S, Yamasaki R.

J Microbiol. 2019 Mar;57(3):213-219. doi: 10.1007/s12275-019-8629-2. Epub 2019 Feb 26. Review.

PMID:
30806978
44.

TAFRO Syndrome with an Anterior Mediastinal Mass and Lethal Autoantibody-Mediated Thrombocytopenia: An Autopsy Case Report.

Morita K, Fujiwara SI, Ikeda T, Kawaguchi SI, Toda Y, Ito S, Ochi SI, Nagayama T, Mashima K, Umino K, Minakata D, Nakano H, Yamasaki R, Kawasaki Y, Sugimoto M, Ashizawa M, Yamamoto C, Hatano K, Sato K, Oh I, Ohmine K, Muroi K, Ashizawa K, Yamamoto Y, Oshiro H, Kanda Y.

Acta Haematol. 2019;141(3):158-163. doi: 10.1159/000492743. Epub 2019 Feb 20.

PMID:
30799408
45.

Cerebrospinal fluid cytokine/chemokine/growth factor profiles in idiopathic hypertrophic pachymeningitis.

Zhang X, Fujii T, Ogata H, Yamasaki R, Masaki K, Cui Y, Matsushita T, Isobe N, Kira JI.

J Neuroimmunol. 2019 May 15;330:38-43. doi: 10.1016/j.jneuroim.2019.01.010. Epub 2019 Feb 13.

PMID:
30784775
46.

MOG antibody disease manifesting as progressive cognitive deterioration and behavioral changes with primary central nervous system vasculitis.

Baba T, Shinoda K, Watanabe M, Sadashima S, Matsuse D, Isobe N, Yamasaki R, Kaneko K, Takahashi T, Iwaki T, Kira JI.

Mult Scler Relat Disord. 2019 May;30:48-50. doi: 10.1016/j.msard.2019.01.053. Epub 2019 Feb 2.

PMID:
30738279
47.

Duplication and deletion upstream of LMNB1 in autosomal dominant adult-onset leukodystrophy.

Mezaki N, Miura T, Ogaki K, Eriguchi M, Mizuno Y, Komatsu K, Yamazaki H, Suetsugi N, Kawajiri S, Yamasaki R, Ishiguro T, Konno T, Nozaki H, Kasuga K, Okuma Y, Kira JI, Hara H, Onodera O, Ikeuchi T.

Neurol Genet. 2018 Dec 7;4(6):e292. doi: 10.1212/NXG.0000000000000292. eCollection 2018 Dec.

48.

Comparison of neutropenia profiles in different treatment protocols for acute myeloid leukemia using the D-index.

Kawasaki Y, Kimura SI, Nakano H, Mashima K, Shirato Y, Kawaguchi SI, Toda Y, Ochi SI, Nagayama T, Minakata D, Yamasaki R, Morita K, Ashizawa M, Yamamoto C, Hatano K, Sato K, Oh I, Fujiwara SI, Ohmine K, Kako S, Muroi K, Kanda Y.

Int J Hematol. 2019 Apr;109(4):470-476. doi: 10.1007/s12185-019-02593-2. Epub 2019 Jan 25.

PMID:
30684252
49.

Anti-neurofascin autoantibody and demyelination.

Kira JI, Yamasaki R, Ogata H.

Neurochem Int. 2019 Nov;130:104360. doi: 10.1016/j.neuint.2018.12.011. Epub 2018 Dec 22. Review.

50.

Downregulation of Neuronal and Dendritic Connexin36-Made Electrical Synapses Without Glutamatergic Axon Terminals in Spinal Anterior Horn Cells From the Early Stage of Amyotrophic Lateral Sclerosis.

Kobayakawa Y, Masaki K, Yamasaki R, Shiraishi W, Hayashida S, Hayashi S, Okamoto K, Matsushita T, Kira JI.

Front Neurosci. 2018 Nov 28;12:894. doi: 10.3389/fnins.2018.00894. eCollection 2018.

Supplemental Content

Loading ...
Support Center